Sun's Cardene ANDA Infringes EKR Patent: Judge
A judge has ruled that generic-drug maker Sun Pharmaceutical Industries Inc. would infringe a patent on EKR Therapeutics Inc.'s intravenous high blood pressure drug Cardene if it were allowed to market...To view the full article, register now.
Already a subscriber? Click here to view full article